Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-28

Clinical Trial Update: Effects of Simvastatin on Biomarkers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of simvastatin on biomarkers in Alzheimer's disease has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Washington | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-07-28